Emerging Markets Show Significant Promise But Multinationals Must Overcome Hurdles – Credit Suisse
This article was originally published in PharmAsia News
Executive Summary
Relatively stagnant growth in developed markets has prompted global pharmaceutical companies to find new sources of revenue in emerging markets that are buoyed by increasing wealth and a growing awareness of the benefits of good health care – though there are roadblocks to progress and high expectations can be confounded.